Notably, semaglutide significantly increased the likelihood of achieving a 2-level reduction in WHO risk drinking level, a clinical trial endpoint recently qualified by the US Food and Drug Administration (FDA), with a number-needed-to-treat of 4.3 suggesting potentially greater efficacy relative to existing alcohol use disorder medications. (!) They see practical applications: GLP-1 therapies could prove effective for reducing drinking levels in mild or prodromal alcohol use disorder, perhaps offering a treatment that can be delivered in primary care. Christian S
BrainMD's Smart Electrolytes Unlike conventional electrolyte products that overload your system with salt, sugar or both, Smart Electrolytes delivers a balanced blend of essential electrolytes potassium and magnesium paired with brain- and body-supportive nutrients like B vitamins and Vitamin C.* Its hydration, upgraded: designed not just to quench thirst, but to optimize the way you feel and function.* Lets dive into what we really mean by the concept of smarter hydration and why its about so much more than salt and water
The goal would be to maintain lean muscle and lose body fat
Accordingly, the list of molecules which have been shown unequivocally to be physiological substrates of DPP-4 is short ( GLP-1 and GIP With regard to metabolic effects, the best characterized DPP-4 substrates are the two incretin hormones, GLP-1, and glucose-dependent insulinotropic polypeptide (GIP)
Great for anyone dealing with dullness, uneven tone, or dark spots
